Valneva announces positive homologous booster data for inactivated, adjuvanted covid-19 vaccine candidate vla2001

Saint herblain ( france), december 16 , 2021 – valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company, today announced positive homologous booster data from the phase 1/2 study, of its inactivated, adjuvanted covid-19 vaccine candidate, vla2001. initial results confirm that vla2001 significantly boosted immunity in participants who received vla2001 as a primary vaccination.
VALN Ratings Summary
VALN Quant Ranking